A positive airway pressure (PAP) mask, which employs compressed air to maintain lung airways during sleep, is the primary therapy for OSA. Some patients with OSA, however, still have EDS and may benefit from anti-fatigue medicine.
Dena Zeraatkar and Tyler Pitre of McMaster University discovered that the medicine solriamfetol is the most effective therapy for excessive daytime sleepiness (EDS) in persons with obstructive sleep apnea (OSA).